DIREXION SHS ETF TR - HEALTHCARE BUL (CURE)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CURE
Type / Class
Equity / HEALTHCARE BUL
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
160,603
Holdings value
$13,403,499
% of all portfolios
0%
Number of holders
22
Number of buys
13
Number of sells
-10
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 160,603 $13,403,499 +$6,201,048 $83.52 22
2025 Q2 104,829 $8,738,642 -$2,121,036 $78.82 21
2025 Q1 119,630 $12,749,419 -$3,651,625 $106.61 21
2024 Q4 162,215 $14,967,674 +$2,061,776 $92.29 23
2024 Q3 117,641 $14,975,249 -$10,934,696 $133.18 19
2024 Q2 209,029 $24,832,086 -$619,320 $116.81 21
2024 Q1 212,892 $26,661,184 +$41,524 $125.45 23
2023 Q4 212,898 $21,651,140 +$427,610 $101.74 21
2023 Q3 211,193 $18,695,500 +$3,185,404 $88.53 20
2023 Q2 172,863 $17,292,257 +$3,960,918 $100.01 20
2023 Q1 111,129 $10,668,334 +$5,851,532 $96 13
2022 Q4 48,370 $5,550,191 -$3,013,993 $114.76 20
2022 Q3 75,620 $6,384,394 +$4,299,088 $84.44 18
2022 Q2 24,736 $2,549,132 -$6,683,921 $103.08 17
2022 Q1 82,130 $10,714,439 -$2,026,081 $130.45 22
2021 Q4 93,191 $13,512,085 +$5,665,143 $144.96 20
2021 Q3 59,622 $6,415,296 +$3,553,188 $107.43 19
2021 Q2 26,189 $2,785,000 -$5,481,399 $104.58 14
2021 Q1 90,189 $7,533,644 -$4,130,827 $83.51 15
2020 Q4 144,746 $11,147,104 +$4,022,795 $77 17
2020 Q3 92,309 $5,870,731 -$7,543,034 $63.02 13
2020 Q2 215,776 $11,724,759 +$1,931,782 $54.33 15
2020 Q1 180,011 $7,164,157 -$2,162,962 $39.83 13
2019 Q4 235,161 $17,326,593 +$160,152 $73.68 16
2019 Q3 234,465 $11,857,425 -$5,213,004 $50.58 19
2019 Q2 328,290 $18,427,033 +$3,683,089 $56.11 17
2019 Q1 262,640 $14,599,783 +$3,499,449 $55.58 12
2018 Q4 199,383 $9,488,000 +$2,674,818 $47.59 13
2018 Q3 141,882 $9,454,545 -$4,674,599 $66.63 11
2018 Q2 248,899 $11,283,000 +$3,462,491 $45.37 18
2018 Q1 173,165 $7,453,000 +$2,373,456 $43.04 16
2017 Q4 116,193 $5,414,000 -$3,613,480 $46.6 14
2017 Q3 193,068 $8,762,000 -$1,411,763 $45.48 9
2017 Q2 240,937 $10,055,260 +$1,264,445 $41.7 14
2017 Q1 181,464 $6,253,820 -$1,133,088 $34.45 13
2016 Q4 239,800 $6,613,000 -$1,863,499 $27.57 14
2016 Q3 295,621 $9,606,340 +$3,157,864 $31.88 15
2016 Q2 198,560 $6,283,000 +$1,143,225 $31.63 11
2016 Q1 159,786 $4,337,840 -$1,605,161 $27.15 12
2015 Q4 211,884 $7,076,400 +$2,802,832 $33.4 12
2015 Q3 127,415 $3,369,280 -$6,207,317 $26.44 9
2015 Q2 262,705 $10,329,920 +$6,738,748 $39.32 11
2015 Q1 69,646 $10,242,669 -$2,877,027 $147.08 12
2014 Q4 96,637 $12,023,156 +$8,809,291 $124.43 13
2014 Q3 23,762 $2,454,980 -$6,256,048 $103.29 5
2014 Q2 94,498 $8,468,740 +$1,164,727 $89.62 9
2014 Q1 83,752 $6,714,255 +$2,631,710 $80.16 6